Filing Details
- Accession Number:
- 0001209191-14-012771
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-21 07:01:09
- Reporting Period:
- 2014-02-20
- Filing Date:
- 2014-02-21
- Accepted Time:
- 2014-02-21 07:01:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103021 | Biodelivery Sciences International Inc | BDSI | Pharmaceutical Preparations (2834) | 352089858 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301715 | A Mark Sirgo | C/O Biodelivery Sciences Intl, Inc., 801 Corporate Center Drive, Suite 210 Raleigh NC 27607 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-20 | 140,000 | $8.90 | 955,250 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2014-02-20 | 42,000 | $8.92 | 913,250 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares of common stock reported on this Form 4 were acquired by the Reporting Person as a result of the vesting of one-third units under a previous Restricted Stock Unit grant.
- The sale of the shares of common stock was made pursuant to a pre-planned 10b5-1 plan.
- On February 20, 2014, the Reporting Person sold an aggregate of 42,000 shares of the Issuer's Common Stock at a weighted average price of $8.92. The highest sale price for the Common Stock was $9.06 per share and the lowest sale price was $8.73 per share.
Billionaire Hedge Funds
